Skip to main content
. Author manuscript; available in PMC: 2009 Feb 1.
Published in final edited form as: Drug Resist Updat. 2008 Apr 18;11(1-2):17–24. doi: 10.1016/j.drup.2008.02.001

Table 1.

Anticipated effects of different TRAIL resistance mechanisms on sensitivity to different therapeutic agonists.

Resistance Mechanism Expected response to Apo2L/TRAIL Expected response to lexatumumab (anti-DR5) Expected response to maptumumab (anti-DR4)
DR5 mutation No apoptosis No apoptosis Apoptosis
Caspase-8 silencing No apoptosis No apoptosis No apoptosis
Increased XIAP No apoptosis No apoptosis No apoptosis
Increased DcR2 No apoptosis Apoptosis Apoptosis